Abstract: Systems and methods for P2P transaction functionality include payment collection from a third party source. A system includes at least one processor and a storage medium storing instructions that, when executed by the one or more processors, cause the at least one processor to perform operations including receiving transaction information from a vendor where a card was used and analyzing the transaction information. The operations also include sending one or more requests for repayment to one or more P2P service systems, receiving repayment information, regarding one or more repayments, from the one or more P2P service systems and, based on the repayment information, applying the one or more repayments to the transaction performed on the card.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: Allelic variations in the genes PLEKHA1 and LOC387715 are identified herein as risk factor for Age Related Maculopathy (ARM). A method is therefore provided for identifying a risk of development of ARM in an individual that comprises identification of allelic variations in PLEKHA1 and/or LOC387715. Related apparatus, such as an array, are identified as being useful in implementing those methods.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: Allelic variations in the genes PLEKHA1 and LOC387715 are identified herein as risk factor for Age Related Maculopathy (ARM). A method is therefore provided for identifying a risk of development of ARM in an individual that comprises identification of allelic variations in PLEKHA1 and/or LOC387715. Related apparatus, such as an array, are identified as being useful in implementing those methods.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: Allelic variations in the genes PLEKHA1 and LOC387715 are identified herein as risk factor for Age Related Maculopathy (ARM). A method is therefore provided for identifying a risk of development of ARM in an individual that comprises identification of allelic variations in PLEKHA1 and/or LOC387715. Related apparatus, such as an array, are identified as being useful in implementing those methods.

Abstract: Allelic variations in the genes PLEKHA1 and LOC387715 are identified herein as risk factor for Age Related Maculopathy (ARM). A method is therefore provided for identifying a risk of development of ARM in an individual that comprises identification of allelic variations in PLEKHA1 and/or LOC387715. Related apparatus, such as an array, are identified as being useful in implementing those methods.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: Methods of preventing or alleviating cardiovascular disease, as well as increasing fibrinolysis levels in a subject, through the identification of subjects with an allele and/or genotype at a gene locus that positively correlates with improved success in increasing fibrinolysis, as compared to other alleles and/or genotypes at the same gene locus, and through engagement of these subjects in exercise training for a period of time sufficient to increase fibrinolysis.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: The invention is a seat for a tailgate or door on an automobile. The invention includes a tailgate for a pickup and a retrofit insert for existing tailgates. The ergonomically shaped seat allows one to sit on a tailgate during tailgating parties or other times when the tailgate is lowered. The seat may also include an accessory attachment device.

Abstract: The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Abstract: The present invention is directed to oxygen sensing. The present invention provides methods for correcting (or providing for) oxygen sensing in cells. Preferably, the methods involve supplying the SDHD gene or cybS protein, or any of the other components of the mitochondrial complex II cytochrome b oxygen sensing complex in an amount which restores oxygen sensing to affected cells, and thus facilitates normoxic conditions. More specifically, the present invention relates to mutations in the SDHD gene in human cancers and their use in the diagnosis and prognosis of mammalian cancer.

Abstract: Methods of reducing blood pressure levels in hypertensive subjects through the identification of subjects with an allele and/or genotype at a gene locus that positively correlates with improved success in reducing blood pressure levels, as compared to other alleles and/or genotypes at the same gene locus, and through the engagement of these subjects in exercise training for a period of time sufficient for the reduction of the subjects' blood pressure levels.